Switzerland-based IFPMA has named Helen Gallagher as its new communications director, it was reported yesterday.
In the new role, Gallagher will act as a spokesperson for the global biopharmaceutical industry trade body in its interaction with stakeholders and the wider global health community.
Prior to her new role at IFPMA, Gallagher headed the corporate communications position at Ferring Pharmaceuticals for 12 years and was also responsible for its corporate social responsibility programme and led its CSR taskforce. Her 20-year career in health and biopharmaceutical communications has included serving in various capacities for Manning Selvage & Lee, Cohn & Wolfe, The Rowland Company and Ciba Speciality Chemicals.
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer